CRBU - CIK 0001619856
Caribou Biosciences, Inc. (CRBU) reported revenue of $11.16M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $11.16M | +11.7% |
| FY 2024 | $9.99M | -71.0% |
| FY 2023 | $34.48M | +148.9% |
| FY 2022 | $13.85M | +44.3% |
| FY 2021 | $9.60M | -22.4% |
| FY 2020 | $12.36M | +113.6% |
| FY 2019 | $5.79M | - |
Caribou Biosciences, Inc. (CRBU) reported revenue of $11.16M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Caribou Biosciences, Inc.'s revenue grew from $5.79M to $11.16M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.